|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin
|
|
Structure:
|
 |
Alpha-thrombin. Chain: l. Alpha-thrombin. Chain: h. Hirugen peptide. Chain: p. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Hirudo medicinalis. Medicinal leech. Organism_taxid: 6421
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
L.Tabernero,J.Sack
|
|
Key ref:
|
 |
L.Tabernero
et al.
(1995).
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
J Mol Biol,
246,
14-20.
PubMed id:
|
 |
|
Date:
|
 |
|
25-Jul-94
|
Release date:
|
15-Oct-95
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00734
(THRB_HUMAN) -
Prothrombin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
622 a.a.
33 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Mol Biol
246:14-20
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
|
|
L.Tabernero,
C.Y.Chang,
S.L.Ohringer,
W.F.Lau,
E.J.Iwanowicz,
W.C.Han,
T.C.Wang,
S.M.Seiler,
D.G.Roberts,
J.S.Sack.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystallographic structure of the ternary complex between human
alpha-thrombin, hirugen and the peptidyl inhibitor Phe-alloThr-Phe-O-CH3, which
is acylated at its N terminus with 4-guanidino butanoic acid (BMS-183507), has
been determined at 2.6 A resolution. The structure reveals a unique
"retro-binding" mode for this tripeptide active site inhibitor. The inhibitor
binds with its alkyl-guanidine moiety in the primary specificity pocket and its
two phenyl rings occupying the hydrophobic proximal and distal pockets of the
thrombin active site. In this arrangement the backbone of the tripeptide forms a
parallel beta-strand to the thrombin main-chain at the binding site. This is
opposite to the orientation of the natural substrate, fibrinogen, and all the
small active site-directed thrombin inhibitors whose bound structures have been
previously reported. BMS-183507 is the first synthetic inhibitor proved to bind
in a retro-binding fashion to thrombin, in a fashion similar to that of the
N-terminal residues of the natural inhibitor hirudin. Furthermore, this new
potent thrombin inhibitor (Ki = 17.2 nM) is selective for thrombin over other
serine proteases tested and may be a template to be considered in designing
hirudin-based thrombin inhibitors with interactions at the specificity pocket.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Toyota,
H.Sekizaki,
Y.U.Takahashi,
K.Itoh,
and
K.Tanizawa
(2005).
Amidino-containing Schiff base copper(II) and iron(III) chelates as a thrombin inhibitor.
|
| |
Chem Pharm Bull (Tokyo),
53,
22-26.
|
 |
|
|
|
|
 |
S.Srivastava,
L.N.Goswami,
and
D.K.Dikshit
(2005).
Progress in the design of low molecular weight thrombin inhibitors.
|
| |
Med Res Rev,
25,
66-92.
|
 |
|
|
|
|
 |
R.Krishnan,
I.Mochalkin,
R.Arni,
and
A.Tulinsky
(2000).
Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
294-303.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Krishnan,
J.E.Sadler,
and
A.Tulinsky
(2000).
Structure of the Ser195Ala mutant of human alpha--thrombin complexed with fibrinopeptide A(7--16): evidence for residual catalytic activity.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
406-410.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.St Charles,
K.Padmanabhan,
R.V.Arni,
K.P.Padmanabhan,
and
A.Tulinsky
(2000).
Structure of tick anticoagulant peptide at 1.6 A resolution complexed with bovine pancreatic trypsin inhibitor.
|
| |
Protein Sci,
9,
265-272.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Lombardi,
G.De Simone,
F.Nastri,
S.Galdiero,
R.Della Morte,
N.Staiano,
C.Pedone,
M.Bolognesi,
and
V.Pavone
(1999).
The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.
|
| |
Protein Sci,
8,
91-95.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Lombardi,
G.De Simone,
S.Galdiero,
N.Staiano,
F.Nastri,
and
V.Pavone
(1999).
From natural to synthetic multisite thrombin inhibitors.
|
| |
Biopolymers,
51,
19-39.
|
 |
|
|
|
|
 |
I.Mochalkin,
and
A.Tulinsky
(1999).
Structures of thrombin retro-inhibited with SEL2711 and SEL2770 as they relate to factor Xa binding.
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
785-793.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.L.Strickland,
J.M.Fevig,
R.A.Galemmo,
B.L.Wells,
C.A.Kettner,
and
P.C.Weber
(1998).
Biochemical and crystallographic characterization of homologous non-peptidic thrombin inhibitors having alternate binding modes.
|
| |
Acta Crystallogr D Biol Crystallogr,
54,
1207-1215.
|
 |
|
|
|
|
 |
G.De Simone,
A.Lombardi,
S.Galdiero,
F.Nastri,
R.Della Morte,
N.Staiano,
C.Pedone,
M.Bolognesi,
and
V.Pavone
(1998).
Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
|
| |
Protein Sci,
7,
243-253.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Tada,
and
J.J.Blow
(1998).
The replication licensing system.
|
| |
Biol Chem,
379,
941-949.
|
 |
|
|
|
|
 |
N.Y.Chirgadze,
D.J.Sall,
V.J.Klimkowski,
D.K.Clawson,
S.L.Briggs,
R.Hermann,
G.F.Smith,
D.S.Gifford-Moore,
and
J.P.Wery
(1997).
The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
|
| |
Protein Sci,
6,
1412-1417.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Caflisch
(1996).
Computational combinatorial ligand design: application to human alpha-thrombin.
|
| |
J Comput Aided Mol Des,
10,
372-396.
|
 |
|
|
|
|
 |
J.H.Matthews,
R.Krishnan,
M.J.Costanzo,
B.E.Maryanoff,
and
A.Tulinsky
(1996).
Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.
|
| |
Biophys J,
71,
2830-2839.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.F.Malley,
L.Tabernero,
C.Y.Chang,
S.L.Ohringer,
D.G.Roberts,
J.Das,
and
J.S.Sack
(1996).
Crystallographic determination of the structures of human alpha-thrombin complexed with BMS-186282 and BMS-189090.
|
| |
Protein Sci,
5,
221-228.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.D.Grootenhuis,
and
M.Karplus
(1996).
Functionality map analysis of the active site cleft of human thrombin.
|
| |
J Comput Aided Mol Des,
10,
1.
|
 |
|
|
|
|
 |
W.F.Lau,
L.Tabernero,
J.S.Sack,
and
E.J.Iwanowicz
(1995).
Molecular modeling studies of novel retro-binding tripeptide active-site inhibitors of thrombin.
|
| |
Bioorg Med Chem,
3,
1039-1048.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|